Impact Factor 4.848 | CiteScore 3.5
More on impact ›
in Oncology |
|
Submit your manuscript
Scope
This section welcomes a broad range of contributions to radiation oncology, from biologically-informed therapeutic regimens and integration of radiation oncology with chemotherapy, surgery and multi-modal approaches, to the development and testing of 3-D and 4-D radiation delivery systems impacting treatment responses and co-morbidities of treatment.
Scope
The field of radiation oncology is currently entering a new frontier of more personalized cancer treatment.
We are being led into this new frontier by the explosion of information in cancer biology. From the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery, and the refinement of more sensitive tumor-imaging technologies for radiation therapy targeting, to an improved understanding of how best to integrate radiation therapy with conventional chemotherapy, newer biologics, as well as surgery, in a multi-modality approach.
This Section welcomes basic and clinical research relating to all aspects of radiation oncology. We are specifically interested in papers on the following topics:
- Identification and characterization of genetic and epigenetic alterations affecting biological signalling networks involved in radiation damage and repair processing in normal and malignant cells/tissues
- Development and testing of 3-D and 4- D radiation treatment delivery systems and/or novel tumor-imaging technologies that impact radiation delivery, treatment response, or morbidities of treatment
- Development and pre- clinical/clinical testing of novel radiation modifying drugs and small molecules
- Integration of systems biology approaches including the development of mathematical and computational models to better bridge the translation from basic to clinical radiation oncology research.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), CLOCKSS
PMCID: all published articles receive a PMCID
Radiation Oncology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Radiation Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact oncology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact oncology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org